Company aims to give AI much broader map of life
Author: Michael
Anavex Life Sciences presented new data from its
NeuroRPM’s FDA-cleared wearable platform will b
ProMIS Neurosciences presented two scientific pos
Unlimited Bio registered a Phase 1/2a clinical tr
Fauna Bio announced the designation of a target u
Garm LLC, doing business as Longevity Advanced, u
RevGenetics launched DiBerberine 300x, an enteric
A peer-reviewed study published in March 2026 by
Elitra Health announced on 20 March 2026 that it